#hellomynameis – Sarah, Research Associate
Latest articles: MGUS is a benign condition which does not usually require treatment. However, a small number of patients diagnosed with MGUS will go on to develop myeloma. Understanding MGUS Monoclonal gammopathy of undetermined significance (MGUS) is a benign...read more
Latest articles: With communication at the heart of GatewayC and fundamental to improving patient care, this blog series focuses on introductions and reflections from the team behind the programme. In this post, we’re introducing Tom, Senior Media Technologist. Could...read more
In this post, we’re introducing Sarah Bellhouse, Research Associate for the GatewayC porgramme.
Could you tell us about your role?
I lead the evaluation component of the GatewayC programme on behalf of Christie Patient Centred Research (CPCR). Funded by Cancer Research UK (CRUK), we are exploring a number of areas, including the impact of GatewayC on GPs in their decision making process. By doing so, we will be able to provide recommendations to the GatewayC team regarding how the online learning can benefit more GPs and be even more effective.
What made you decide to join the GatewayC team?
As a member of CPCR, our research focuses on improving patient experience and one of our key themes is cancer prevention and early detection. Both of these aims are shared by GatewayC, so joining the team was an opportunity not to be missed.
What makes GatewayC unique?
GatewayC is flexible learning at its best; the variety of exercises and dip in dip out style of learning ensures that there is something to suit every GP.
Finally, could you tell us an interesting fact about yourself?
For 8 years I was part of a dance and drama studio learning ballet, tap, jazz and street dance. I successfully auditioned for a role in Fagin’s gang in a theatre production of Oliver which starred Al T Kossy of Brookside fame.
For more information about GatewayC, visit the website at www.gatewayc.org.uk or follow the team on social media: